Raymond James Financial, Inc.

  • Market Cap: Mid Cap
  • Industry: Capital Markets
  • ISIN: US7547301090
USD
162.60
3.81 (2.4%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Raymond James Financial, Inc. stock-summary
stock-summary
Raymond James Financial, Inc.
Capital Markets
Raymond James Financial, Inc. (RJF) is a financial holding company. The Company's subsidiaries include Raymond James & Associates, Inc. (RJ&A), Raymond James Financial Services, Inc. (RJFS), Raymond James Financial Services Advisors, Inc. (RJFSA), Raymond James Ltd. (RJ Ltd.), Eagle Asset Management, Inc. (Eagle), and Raymond James Bank, N.A. (RJ Bank). It operates through five segments: Private Client Group (PCG), Capital Markets, Asset Management, RJ Bank and the Other segment. The Private Client Group segment includes the retail branches of the Company's broker-dealer subsidiaries located throughout the United States, Canada and the United Kingdom. The Capital Markets segment includes institutional sales and trading in the United States, Canada and Europe. The Asset Management segment includes the operations of Eagle, the Eagle Family of Funds and other fee-based asset management programs. RJ Bank segment provides corporate loan, securities based loans (SB) and residential loans.
Company Coordinates stock-summary
Company Details
880 Carillon Pkwy , ST PETERSBURG FL : 33716-1102
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 136 Schemes (41.5%)

Foreign Institutions

Held by 317 Foreign Institutions (13.44%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Paul Reilly
Chairman of the Board, Chief Executive Officer
Mr. Thomas James
Chairman Emeritus
Ms. Susan Story
Lead Non-Executive Independent Director
Mr. Jeffrey Edwards
Non-Executive Independent Director
Ms. Marlene Debel
Non-Executive Independent Director
Mr. Robert Dutkowsky
Non-Executive Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
3,901 Million
(Quarterly Results - Jun 2025)
Net Profit:
436 Million
stock-summary
Industry

Capital Markets

stock-summary
Market cap

USD 38,576 Million (Mid Cap)

stock-summary
P/E

16.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

51.96%

stock-summary
Debt Equity

-999,999.00

stock-summary
Return on Equity

17.43%

stock-summary
Price to Book

3.15